da Vinci® Transoral Robotic Surgery (TORS)
If you have early to moderate stage throat cancer, your doctor may recommend surgery. If you are facing throat cancer surgery, ask your doctor about da Vinci Surgery.
Why da Vinci Surgery?
The da Vinci System allows your surgeon to operate through the mouth – similar to other minimally invasive approaches. The da Vinci System features a magnified 3D high-definition vision system and special wristed instruments that bend and rotate far greater than the human wrist. da Vinci enables your surgeon to operate with enhanced vision, precision, dexterity and control.
As a result of the da Vinci technology, potential benefits of da VinciTransoral Robotic Surgery include:
- Precise removal of cancerous tissue1,2,3
- Low rate of complications2,3
- Low blood loss3,4
- Minimal need for tracheotomy (breathing tube)4
- Minimal need for chemoradiation therapy1,2
- Ability to swallow following surgery1,2,3,4
- Short hospital stay4
- No visible scarring or disfigurement5
State-of-the-art da Vinci uses the latest in surgical and robotics technologies and is beneficial for performing complex surgery. Your surgeon is 100% in control of the da Vinci System, which translates his or her hand movements into smaller, more precise movements of tiny instruments inside your body. da Vinci – taking surgery beyond the limits of the human hand.
Physicians have used the da Vinci System successfully worldwide in approximately 1.5 million various surgical procedures to date. da Vinci is changing the experience of surgery for people around the world.
Risks & Considerations Related to Throat Cancer Surgery:
Potential risks of any throat cancer procedure include:
- Vocal cord damage
- Speech and swallowing dysfunction
- Need for a tracheostoma (hole in neck) to breathe
There are potential risks related to minimally invasive surgery, including da Vinci TORS, such as post-operative hemorrhage and bleeding at the surgical site.6
To locate a da Vinci surgeon nearest you, use our surgeon locator.
- Weinstein GS, Quon H, O'Malley BW Jr, Kim GG, Cohen MA. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope. 2010 Sep;120(9):1749-55
- White HN, Moore EJ, Rosenthal EL, Carroll WR, Olsen KD, Desmond RA, Magnuson JS. Transoral robotic-assisted surgery for head and neck squamous cell carcinoma – one- and 2-year survival analysis. Laryngoscope. 2010 Sep;120(9):1749-55.
- Weinstein GS, O’Malley Jr. BW, Synder W, Sherman E, Quon H. Transoral robotic surgery, radical tonsillectomy. Arch Otolaryngol, Head Neck Surg, Dec 2007;133(12).
- Boudreaux BA, Rosenthal EL, Magnuson SJ, Newman RJ,, Desmond RA, Clemons L, Carroll WR; Robot-Assisted Surgery for Upper Aerodigestive Tract Neoplasms; Arch Otolaryngol Head Neck Surg/Vol 135 (No. 4), Apr 2009.
- Weinstein GS,O’Malley Jr BS, Desai SC, Quon H. Transoral robotic surgery: does the ends justify the means? Current Opinion in Otolaryngology & Head and Neck Surgery, 2009;17:126–131.
- Salassa JR, Hinni ML, Grant DG, Hayden RE. Postoperative bleeding in transoral laser microsurgery for upper aerodigestive tract tumors. Otolaryngol Head Neck Surg. 2008 Sep;139(3):453-9. doi: 10.1016/j.otohns.2008.06.010.
The da Vinci System is indicated for transoral otolaryngologic surgical procedures (i.e., use in removing tumors from the mouth, tonsils, tongue and throat through the mouth), but restricted to cancerous and non-cancerous tumors classified as T1 and T2 (i.e., early and mid stage cancers only). The da Vinci® System is not indicated for pediatric transoral otolaryngology surgical procedures. The safety and effectiveness of the da Vinci Surgical System has not been established in patients with poor mouth openings (< 1.5 cm), advanced tumors (e.g., invading the mandible, abutting the carotid artery, requiring bone resection, etc.). The da Vinci® System is not recommended for use in dental surgery (i.e. tooth extraction).
Important Safety Information
Serious complications may occur in any surgery, including da Vinci® Surgery, up to and including death. Individual surgical results may vary. Patients should talk to their doctor to decide if da Vinci Surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options in order to make an informed decision. Please also refer to http://www.daVinciSurgery.com/Safety for Important Safety Information.
When Is Single-Site Technology Used and What Are the Risks?
da Vinci Surgery with Single-Site® Instruments is cleared for use in gallbladder removal, and for hysterectomy and ovary removal for benign conditions. Patients who are not candidates for non-robotic minimally invasive surgery are also not candidates for da Vinci Surgery, including da Vinci Surgery with Single-Site Instruments. There may be an increased risk of incision-site hernia with single-incision surgery, including Single-Site surgery with the da Vinci System. Single-Site® Instruments for the da Vinci® Si™ System bear the CE mark. This device is cleared for commercial distribution in the U.S. for laparoscopic cholecystectomy, and for hysterectomy and salpingo-oophorectomy for benign conditions.
© 2015 Intuitive Surgical, Inc. All rights reserved. Product names are trademarks or registered trademarks of their respective holders.